A Study to Assess DF6002 (BMS-986415) Alone and in Combination With Nivolumab in Participants With Locally Advanced or Metastatic Solid Tumors Read more about A Study to Assess DF6002 (BMS-986415) Alone and in Combination With Nivolumab in Participants With Locally Advanced or Metastatic Solid Tumors
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Read more about Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER) Read more about A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Read more about Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Project: Every Child for Younger Patients With Cancer Read more about Project: Every Child for Younger Patients With Cancer
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) Read more about Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)